3 recruiting, 2 completed, 1 terminated, 1 unknown. 5 Phase 2, 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Completed 1, Withdrawn 1 |
| Phase 3 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Salovum: new trials by email Literature Review of Salovum trials Research Report on Salovum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma Salovum - Glioblastoma | Phase 2 | Recruiting | Peter Siesjö | 10 | 2024-10-07 | 2026-01-23 |
| Antisecretory Factor Glioblastoma Phase 2 Salovum, Placebo egg yolk powder - Glioblastoma | Phase 2 / Phase 3 | Recruiting | Peter Siesjö | 300 | 2024-01-15 | 2026-01-09 |
| Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer SPC-flakes, Salovum, Placebo - Early-stage Breast Cancer, Diarrhea | Phase 3 | Unknown | Henrik Lindman | 100 | 2023-06-07 | 2023-11-30 |
| Antisecretory Factor In Severe Traumatic Brain Injury Salovum, Placebo egg yolk powder - Traumatic Brain Injury | Phase 2 | Recruiting | Peter Siesjö | 20 | 2020-03-10 | 2026-01-21 |
| Antisecretory Factor in Primary Glioblastoma 1 Salovum - Glioblastoma, Cerebral Edema | Phase 1 / Phase 2 | Completed | Peter Siesjö | 8 | 2019-09-01 | 2021-04-28 |
| Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury Salovum - Head Trauma, Intensive Care Neurological Disorder | Phase 2 | Withdrawn | Peter Siesjö | 2018-03-01 | 2018-12-12 | |
| Effect of Antisecretory Factor, Given as a Food Supplement to Adult Patients With Severe Traumatic Brain Injury Salovum, Placebo - Brain Trauma | Phase 3 | Completed | Peter Siesjö | 100 | 2017-09-17 | 2022-10-12 |
| Antisecretory Factor (AF) Effects on Intraocular-pressure Salovum, Placebo - Glaucoma | Phase 3 | Terminated | St. Erik Eye Hospital | 50 | 2016-04-01 | 2021-05-14 |
Brain Edema (3) · Brain Injuries, Traumatic (3) · Glioblastoma (3) · Breast Neoplasms (1) · Craniocerebral Trauma (1) · Diarrhea (1) · Drug-Related Side Effects and Adverse Reactions (1) · Glaucoma (1)
Peter Siesjö (6) · Henrik Lindman (1) · St. Erik Eye Hospital (1)
Sweden (6) · South Africa (1)
Adriaan J Vlok, Professor (1) · Charlotte Edwardsson (1) · David Cederberg, Consultant (1) · Enping Chen, MD PhD (1) · Erik Ehinger, MD (1) · Henrik Lindman, MD, PhD (1)
PMID 35461285, PMID 36803465, PMID 39920739, PMID 40083039, PMID 42705343
2019 (1)